Inflammatory Bowel Disease Flashcards
1
Q
Inflammatory Bowel Disease (IBD)
A
- Umbrella Term
- Crohn’s Disease
- Ulcerative Colitis
2
Q
IBD Etiology
A
- Thought to be complex interplay
- Genetics
- Immunes system
- Environmental factors
- Genetic Predisposition
- Positive family history is highest risk for IBD
- 1st degree relatives
- Gene mutation on chromosomes 5 and 6 (just FYI)
- Positive family history is highest risk for IBD
- Smokers 2 – 4 x’s risk for Crohn’s
- More aggressive disease
- Non-smokers greater risk for ulcerative colitis
3
Q
IBD Epidemiology
A
- Worldwide
- Usually industrialized nations
- Urban area
- Cold climate
- USA and Northern Europe
- Jewish greatest prevalence
- Native American, Asian, Hispanic least prevalent
- Caucasian women
- 15 -25 years peak
- Another peak 55 – 65 years
- 15 -25 years peak
- Usually industrialized nations
4
Q
Pathophysiology of IBD
A
- Inflammation
- Exacerbation and remission
- Crohn’s vs Ulcerative colitis
5
Q
Ulcerative Colitis
A
Bowel mucosa
- Diffuse and continuous inflammation
- Edema and shallow ulceration
- Distal colorectal area – 40 -50%
- Left sided : colorectal to splenic flexure 30 – 40%
- Severe disease : extends up to hepatic flexure
- Rectum only (very small %) ulcerative proctitis.
- Mucosa is fragile
- Bleeds spontaneously
- Trauma
- Bleeds spontaneously
- Becomes thickened and edematous
- Scars form
- Lose elasticity and absorptive capability
- Scars form
6
Q
UC S/S
A
- Bloody Diarrhea
- 3-4 x’s/day up to hourly
- Small in volume
- Mushy
- Mixed with blood, mucus, and pus
- 3-4 x’s/day up to hourly
- Abdominal pain
- Left-sided
- Colicky
- Relieved by emptying bowel
7
Q
Crohn’s Disease
A
Affects any portion of the digestive tract
- Most often proximal colon and ileocecal junction
- “Right-sided” disease
- 40% confined to cecum and ileum
- May be in more than one site
- Transmural
- All layers of the intestinal wall
- “Skip” or “Cobblestone” pattern
- Affected tissue separated by normal tissue
- What do the lesions do?
- Perforate
- Form fistulas
- Scar tissue
- ↓ absorption
- Strictures
- Bowel obstruction
- Polyps
8
Q
Chron’s S/S
A
- Varies according to location and severity
- Diarrhea
-
Small intestine
- 3 – 5 large semi-solid stool/day
- Contains mucus and pus
- No blood
- Contains mucus and pus
- 3 – 5 large semi-solid stool/day
-
High small intestine
- Steatorrhea
- Fatty stool, foul smelling
- Poor absorption of fat soluble vitamins
- A, D, E, and K
- Steatorrhea
-
Small intestine
- Abdominal pain
- Colicky and severe
- Occurs after eating
- Diffuse or
- Localized in RLQ
- May resemble appendicitis
9
Q
Systemic Symptoms of IBD
A
- Related to the intestines
- Anorexia, Nausea, Weakness, Malaise
- Weight loss
- Nutritional deficiencies R/T poor absorption
- Labs
- Anemia – iron deficiency
10
Q
Extraintestinal symptoms of IBD
A
- Can involve every organ in the body
- Etiology not well understood
-
Arthritis (up to 23%)
-
Large joints
- As IBD improves, so does Arthritis
-
Large joints
-
Ocular (up to 10%)
- Uveitis, retinopathy
-
Renal (up to 23%)
- Kidney stones
-
Skin (3 – 6%)
-
Erythema nodosum
- Red, tender nodule on anterior tibia
-
Erythema nodosum
-
Hepatobiliary (4 – 5%)
- Cholelithiasis, Fatty liver
- Cholangitis (70% have UC)
11
Q
Complications of IBD
A
Primary
- Hemorrhage
- Obstructions
- Perforation
- Toxic megacolon
- Cellular dysplasia or Cancer
- Adenocarcinoma
- UC 10 – 20 X’s more than general population
- Crohn’s Dz 4 – 7 X’s more than general population
- Adenocarcinoma
12
Q
IBD Diagnostic Tests
A
- Health history
- Symptoms
- Pattern of severity and duration
- Labs
- Stool cultures
- Fecal leukocytes and parasites
- CBC, ESR, Serum albumin
-
Serologic antibody assay
- Preinuclear antineutrophil cytoplasmic antibodies (pANCA)
- Ulcerative colitis
- Anti-Saccharonyce cerevisiae antibodies (ASCA)
- Crohn’s Disease
- Differentiates IBD from IBS
- Preinuclear antineutrophil cytoplasmic antibodies (pANCA)
- Radiologic
- Barium enema
- Evaluate physical changes of colon
- Structure of bowel
- String lesions – Crohn’s Dz.
- Structure of bowel
- Evaluate physical changes of colon
- CT of Abdomen
- Transabdominal ultrasound
- Barium enema
13
Q
IBD Medications
A
- Stepped Approach
- Progressed until a response occurs
- Step 1 – Aminosalicylates
- Step 1a – Antibiotics
- Step 2 – Corticosteroids
- Step 3 – Immunomodulatory agents
- Monoclonal antibodies
- Step 4 – Agents that have been shown to help selected types of patients
14
Q
Step 1 (mild to moderate IBD)
A
- Aminosalicylates
-
Sufasalazine (Azulfidine)
- Developed in the 1930’s to treat arthritis
- Combination of sulfa drug and aspirin
- Broken down in colon into Sulfapyridine and 5-acetysailcylic acid (5-ASA)
- 5-ASA not absorbed, so stays in colon to reduce inflamation
- Sulfa does not really do anything
- Olsalazine (Dipentum) 5-ASA
-
Mesalamine (Pentasa, Asacol)
- pH sensitive coating – releases in colon
-
Sufasalazine (Azulfidine)
15
Q
Step 1A
A
-
Antibiotic
- Metronidazole (Flagyl)
- Ciprofloxacin (Cipro)
- Most often used in pre-op care
- Can be used in seriously ill with infection